BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 94 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 2.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $175,500 | -66.9% | 97,500 | -68.9% | 0.05% | -65.7% |
| Q3 2022 | $530,000 | -31.3% | 313,600 | 0.0% | 0.14% | -31.9% |
| Q2 2022 | $771,000 | -11.3% | 313,600 | 0.0% | 0.21% | -7.1% |
| Q1 2022 | $869,000 | -20.9% | 313,600 | +52.2% | 0.23% | -18.1% |
| Q4 2021 | $1,099,000 | – | 206,100 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $5,830,000 | 0.29% |
| K2 PRINCIPAL FUND, L.P. | 1,031,511 | $1,743,000 | 0.20% |
| Boxer Capital, LLC | 2,014,858 | $3,405,000 | 0.19% |
| DAFNA Capital Management LLC | 313,600 | $530,000 | 0.14% |
| Newtyn Management, LLC | 350,000 | $592,000 | 0.13% |
| Artal Group S.A. | 1,646,517 | $2,783,000 | 0.12% |
| Bellevue Group AG | 4,717,113 | $7,972,000 | 0.11% |
| MPM BioImpact LLC | 239,888 | $405,000 | 0.10% |
| RA Capital Management | 2,589,904 | $4,377,000 | 0.09% |
| Beacon Capital Management, LLC | 35,615 | $88,000 | 0.03% |